✦ LIBER ✦

ED1: COST-EFFECTIVENESS OF INTENSIVE METFORMIN VERSUS CONVENTIONAL THERAPY FOR OBESE PATIENTS WITH TYPE 2 DIABETES

✍ Scribed by AJ Palmer; PP Sendi; V Gozzoli; A Brandt; GA Spinas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB27 COST-EFFECTIVENESS ANALYSIS OF MET

✍ J. Elgart; J. Caporale; E.C. Aiello; M. Waschbusch; L. Jotimliansky; J.J. Gaglia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Intensive versus conventional glycemic c

✍ Ahmed, Almoutaz Alkhier; Alsharief, Emad; Alsharief, Ali 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 187 KB

Incretin Therapy for Patients with Type

✍ Ramirez de Arellano, A.; Hunt, B.; Mezquita Raya, P.; Briones, T.; Pérez, A.; Va 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PDB56 Evaluating the Short-Term Cost-Eff

✍ J. Langer; B. Hunt; W.J. Valentine 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

DB3 COST-EFFECTIVENESS OF ROSIGLITAZONE-

✍ A Shearer; A Bagust; O Schoeffski; U Reitberger; A Goertz; M Behrens 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Antithrombotic Effects of Rosiglitazone-

✍ Dr. Giuseppe Derosa; Dr. Antonio V. Gaddi; Dr. Mario N. Piccinni; Dr. Leonardina 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB